We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$13.7B
AUM Growth
-$178M
Cap. Flow
-$1.14B
Cap. Flow %
-8.27%
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100

Sector Composition

Rank Sector Weight
1 Technology 26.03%
2 Healthcare 12.56%
3 Financials 11.14%
4 Consumer Discretionary 11.03%
5 Industrials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPE
1201
DELISTED
Callon Petroleum Company
CPE
$1.13M 0.01%
32,321
+6,684
+26% +$224K
DEI icon
1202
Douglas Emmett
DEI
$1.97B
$1.13M 0.01%
89,825
-17,829
-17% -$215K
EPC icon
1203
Edgewell Personal Care
EPC
$1.32B
$1.13M 0.01%
27,280
EQC
1204
DELISTED
Equity Commonwealth
EQC
$1.12M 0.01%
55,517
+576
+1% +$11.9K
AMR icon
1205
Alpha Metallurgical Resources
AMR
$2.05B
$1.12M 0.01%
6,839
-1,142
-14% -$175K
CPK icon
1206
Chesapeake Utilities
CPK
$3.26B
$1.12M 0.01%
9,433
+181
+2% +$22.9K
URBN icon
1207
Urban Outfitters
URBN
$6.66B
$1.12M 0.01%
33,836
+523
+2% +$15.3K
STR
1208
DELISTED
Sitio Royalties
STR
$1.12M 0.01%
42,582
+5,359
+14% +$137K
SHO icon
1209
Sunstone Hotel Investors
SHO
$2.04B
$1.11M 0.01%
110,170
NMIH icon
1210
NMI Holdings
NMIH
$3.43B
$1.11M 0.01%
43,164
RVNC
1211
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.11M 0.01%
43,980
+1,653
+4% +$51.5K
DORM icon
1212
Dorman Products
DORM
$3.99B
$1.11M 0.01%
14,073
+219
+2% +$18.4K
NTCT icon
1213
NETSCOUT
NTCT
$2.88B
$1.11M 0.01%
35,768
-1,334
-4% -$39.2K
SDRL icon
1214
Seadrill
SDRL
$3.02B
$1.11M 0.01%
+26,797
New +$995K
AKRO
1215
DELISTED
Akero Therapeutics
AKRO
$1.11M 0.01%
23,684
+5,405
+30% +$248K
FOX icon
1216
Fox Class B
FOX
$25.7B
$1.1M 0.01%
34,631
-969
-3% -$29.3K
SFBS
1217
ServisFirst Bancshares
SFBS
$5.02B
$1.1M 0.01%
26,912
+963
+4% +$44.5K
TRN icon
1218
Trinity Industries
TRN
$2.36B
$1.1M 0.01%
42,682
B
1219
DELISTED
Barnes Group Inc.
B
$1.09M 0.01%
25,863
+379
+1% +$15.4K
CBRL icon
1220
Cracker Barrel
CBRL
$1.27B
$1.09M 0.01%
11,698
ARCH
1221
DELISTED
Arch Resources, Inc.
ARCH
$1.09M 0.01%
9,655
+1,698
+21% +$204K
KKR icon
1222
KKR & Co
KKR
$104B
$1.09M 0.01%
19,416
+7,567
+64% +$396K
PI icon
1223
Impinj
PI
$5.28B
$1.09M 0.01%
12,125
+1,075
+10% +$115K
GLNG icon
1224
Golar LNG
GLNG
$5.28B
$1.09M 0.01%
53,822
VIR icon
1225
Vir Biotechnology
VIR
$1.53B
$1.08M 0.01%
44,157
+6,400
+17% +$161K

Similar funds

MetLife Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.

  • MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
  • MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
  • MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
  • MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
  • MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
  • MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.

Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.